Arrivent Biopharma Inc (AVBP)

Apr 30, 2026

FY2026 Earnings Estimate for AVBP Issued By Lifesci Capital - MarketBeat

Apr 30, 2026

Apr 29, 2026

ArriVent BioPharma: A First Assessment (NASDAQ:AVBP) - Seeking Alpha

Apr 29, 2026

Apr 28, 2026

[ARS] ArriVent BioPharma, Inc. SEC Filing - Stock Titan

Apr 28, 2026

Apr 28, 2026

ArriVent BioPharma (NASDAQ: AVBP) details 2026 virtual meeting, board elections and CEO pay - Stock Titan

Apr 28, 2026

Apr 27, 2026

Buy Rating Reaffirmed on ArriVent as Firmonertinib Data Boost Confidence; $42 Price Target Maintained - TipRanks

Apr 27, 2026

Apr 25, 2026

Why (AVBP) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Apr 25, 2026

Apr 24, 2026

Are you looking for a top momentum pick? Why ArriVent BioPharma, Inc. (AVBP) is a great choice - MSN

Apr 24, 2026

Apr 24, 2026

Citigroup Increases ArriVent BioPharma (NASDAQ:AVBP) Price Target to $45.00 - MarketBeat

Apr 24, 2026

Apr 24, 2026

Citi Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Raises Target Price to $45 - Moomoo

Apr 24, 2026

Apr 24, 2026

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Apr 24, 2026

Apr 24, 2026

Cantor Fitzgerald initiates coverage of ArriVent BioPharma (AVBP) with overweight recommendation - MSN

Apr 24, 2026

Apr 23, 2026

Are medical stocks lagging ArriVent BioPharma, Inc. (AVBP) this year? - MSN

Apr 23, 2026

Apr 22, 2026

ArriVent BioPharma (NASDAQ:AVBP) Hits New 12-Month HighWhat's Next? - MarketBeat

Apr 22, 2026

Apr 21, 2026

Vicor, AXT And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Apr 21, 2026

Apr 18, 2026

Stocks generating improved relative strength: ArriVent BioPharma - MSN

Apr 18, 2026

Apr 18, 2026

What macro factors move ArriVent (AVBP) stock most (Stalls) 2026-04-18Community Risk Signals - Xã Vĩnh Công

Apr 18, 2026

Apr 17, 2026

Arrivent Biopharma stock hits 52-week high at $29.56 By Investing.com - Investing.com Australia

Apr 17, 2026

Apr 17, 2026

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring a 38.82% Upside Potential in the Biotech Sector - DirectorsTalk Interviews

Apr 17, 2026

Apr 16, 2026

Arrivent Biopharma stock hits 52-week high at $29.56 - Investing.com

Apr 16, 2026

Apr 16, 2026

Are medical stocks lagging AstraZeneca (AZN) this year? - MSN

Apr 16, 2026

Apr 16, 2026

ArriVent BioPharma (NASDAQ:AVBP) Hits New 1-Year HighTime to Buy? - MarketBeat

Apr 16, 2026

Apr 15, 2026

Wall Street analysts think ArriVent BioPharma, Inc. (AVBP) could surge 72.44%: Read this before placing a bet - MSN

Apr 15, 2026

Apr 15, 2026

Are You Looking for a Top Momentum Pick? Why ArriVent BioPharma, Inc. (AVBP) is a Great Choice - Yahoo Finance

Apr 15, 2026

Apr 14, 2026

Understanding Momentum Shifts in (AVBP) - Stock Traders Daily

Apr 14, 2026

Apr 13, 2026

Are Medical Stocks Lagging AstraZeneca (AZN) This Year? - Yahoo Finance

Apr 13, 2026

Apr 11, 2026

Guggenheim Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $45 - Moomoo

Apr 11, 2026

Apr 10, 2026

ArriVent BioPharma (NASDAQ:AVBP) Sets New 12-Month HighShould You Buy? - MarketBeat

Apr 10, 2026

Apr 09, 2026

Surprises Report: How does SAPH compare to its peers2026 Macro Impact & AI Based Buy/Sell Signal Reports - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Arrivent Biopharma stock hits 52-week high at 27.25 USD By Investing.com - Investing.com Australia

Apr 09, 2026

Apr 09, 2026

Arrivent Biopharma stock hits 52-week high at 27.25 USD - Investing.com

Apr 09, 2026

Apr 08, 2026

Is ArriVent (AVBP) Stock Risky Now | Price at $25.23, Up 0.16%Turnaround Stocks - Newser

Apr 08, 2026

Apr 06, 2026

ArriVent BioPharma, Inc. (AVBP) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 06, 2026

Apr 06, 2026

Wall Street Analysts Think ArriVent BioPharma, Inc. (AVBP) Could Surge 72.44%: Read This Before Placing a Bet - Yahoo Finance

Apr 06, 2026

Apr 06, 2026

Is ArriVent (AVBP) Stock Declining | Price at $25.23, Up 1.37%Shared Buy Zones - Newser

Apr 06, 2026

Apr 05, 2026

Wall Street experts predict that ArriVent BioPharma, Inc. (AVBP) may climb by 72.44%. Check this out before making any investment decisions. - bitget.com

Apr 05, 2026

Apr 05, 2026

ArriVent to present preclinical cancer drug data at AACR 2026 - MSN

Apr 05, 2026

Apr 04, 2026

Assessing ArriVent BioPharma (AVBP) Valuation After Recent Share Price Momentum And Pipeline Interest - Yahoo Finance

Apr 04, 2026

Apr 04, 2026

AVBP Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Avoiding Lag: Real-Time Signals in (AVBP) Movement - Stock Traders Daily

Apr 03, 2026

Apr 03, 2026

AVBP Q4 2025 Earnings: ArriVent BioPharma Inc. tops EPS views, no revenue - Cổng thông tin điện tử Tỉnh Sơn La

Apr 03, 2026

Apr 02, 2026

Clear Street Initiates Coverage of ArriVent BioPharma (AVBP) with Buy Recommendation - MSN

Apr 02, 2026

Apr 01, 2026

Gains Report: Whats next for ArriVent BioPharma Inc stock2026 Technicals & Weekly Breakout Stock Alerts - baoquankhu1.vn

Apr 01, 2026

Mar 31, 2026

Aug Highlights: How do insiders feel about ArriVent BioPharma IncAnalyst Upgrade & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

ArriVent BioPharma (NASDAQ:AVBP) Trading Up 8.4%Here's Why - MarketBeat

Mar 31, 2026

Mar 30, 2026

Aug Mood: Can ArriVent BioPharma Inc maintain sales growth2026 Investor Takeaways & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 30, 2026

Mar 30, 2026

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Mar 30, 2026

Mar 29, 2026

Assessing ArriVent BioPharma (AVBP) Valuation After Recent Share Price Momentum Shift - Sahm

Mar 29, 2026